These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 15574176)
1. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. Verma A; Kilicaslan F; Marrouche NF; Minor S; Khan M; Wazni O; Burkhardt JD; Belden WA; Cummings JE; Abdul-Karim A; Saliba W; Schweikert RA; Tchou PJ; Martin DO; Natale A J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1265-70. PubMed ID: 15574176 [TBL] [Abstract][Full Text] [Related]
2. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Brigadeau F; Kouakam C; Klug D; Marquié C; Duhamel A; Mizon-Gérard F; Lacroix D; Kacet S Eur Heart J; 2006 Mar; 27(6):700-7. PubMed ID: 16421175 [TBL] [Abstract][Full Text] [Related]
3. Characteristics and relevance of clustering ventricular arrhythmias in defibrillator recipients. Stuber T; Eigenmann C; Delacrétaz E Pacing Clin Electrophysiol; 2005 Jul; 28(7):702-7. PubMed ID: 16008807 [TBL] [Abstract][Full Text] [Related]
4. Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm. Streitner F; Kuschyk J; Veltmann C; Ratay D; Schoene N; Streitner I; Brueckmann M; Schumacher B; Borggrefe M; Wolpert C Cytokine; 2009 Sep; 47(3):166-72. PubMed ID: 19604708 [TBL] [Abstract][Full Text] [Related]
5. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study. Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ; J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671 [TBL] [Abstract][Full Text] [Related]
7. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators. Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804 [TBL] [Abstract][Full Text] [Related]
8. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. Lampert R; McPherson CA; Clancy JF; Caulin-Glaser TL; Rosenfeld LE; Batsford WP J Am Coll Cardiol; 2004 Jun; 43(12):2293-9. PubMed ID: 15193696 [TBL] [Abstract][Full Text] [Related]
9. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333 [TBL] [Abstract][Full Text] [Related]
10. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
11. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Carbucicchio C; Santamaria M; Trevisi N; Maccabelli G; Giraldi F; Fassini G; Riva S; Moltrasio M; Cireddu M; Veglia F; Della Bella P Circulation; 2008 Jan; 117(4):462-9. PubMed ID: 18172038 [TBL] [Abstract][Full Text] [Related]
12. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery. Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124 [TBL] [Abstract][Full Text] [Related]
13. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK; J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248 [TBL] [Abstract][Full Text] [Related]
14. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study. Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA; J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071 [TBL] [Abstract][Full Text] [Related]
15. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators. Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820 [TBL] [Abstract][Full Text] [Related]
16. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Haigney MC; Zareba W; Gentlesk PJ; Goldstein RE; Illovsky M; McNitt S; Andrews ML; Moss AJ; J Am Coll Cardiol; 2004 Oct; 44(7):1481-7. PubMed ID: 15464332 [TBL] [Abstract][Full Text] [Related]
17. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Greene M; Newman D; Geist M; Paquette M; Heng D; Dorian P Europace; 2000 Jul; 2(3):263-9. PubMed ID: 11227599 [TBL] [Abstract][Full Text] [Related]
18. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator. Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756 [TBL] [Abstract][Full Text] [Related]
19. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. Whang W; Albert CM; Sears SF; Lampert R; Conti JB; Wang PJ; Singh JP; Ruskin JN; Muller JE; Mittleman MA; J Am Coll Cardiol; 2005 Apr; 45(7):1090-5. PubMed ID: 15808769 [TBL] [Abstract][Full Text] [Related]